Not applicableStudy completedNCT00330538What this trial is testingOsteoporosis in Children With ALLWho this might be right forLeukemia, Lymphocytic, Acute, L1 Children's Mercy Hospital Kansas City 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06652685What this trial is testingMolecular Subtype Combined with Early Minimal Residual Disease to Optimize the Treatment of Newly Diagnosed Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia (AML) Ruijin Hospital 218
Not applicableNot Yet RecruitingNCT07691008What this trial is testingWearable Data for Personalized Prognostication in Cancer: A Registry ProtocolWho this might be right forHematopoietic NeoplasmMalignant Solid NeoplasmLymphatic System Neoplasm+1 more City of Hope Medical Center 1,200
Testing effectiveness (Phase 2)Study completedNCT03439293What this trial is testingIxazomib+Daratumumab+Dexamethasone (IDd) in Relapsed and/or Refractory Multiple Myeloma (RRMM)Who this might be right forMultiple Myeloma Takeda 61
Not applicableWithdrawnNCT05943314What this trial is testingClinical Study on Safety and Efficacy of Anti-CLL1 /+CD33 CAR T Cells in the Treatment of Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia Guangzhou Bio-gene Technology Co., Ltd
Testing effectiveness (Phase 2)WithdrawnNCT00845104What this trial is testingFludarabine Phosphate, Rituximab, and Bevacizumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia That Has Relapsed or Not Responded To TreatmentWho this might be right forB-cell Chronic Lymphocytic LeukemiaRefractory Chronic Lymphocytic Leukemia Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Testing effectiveness (Phase 2)UnknownNCT03940833What this trial is testingClinical Research of Adoptive BCMA CAR-NK Cells on Relapse/Refractory MMWho this might be right forMultiple Myeloma Asclepius Technology Company Group (Suzhou) Co., Ltd. 20
Testing effectiveness (Phase 2)Temporarily pausedNCT02910752What this trial is testingCLAM Chemotherapy With PBSC Support for Relapsed Patients After Allogeneic Stem Cell TransplantationWho this might be right forLeukemia Shanghai Jiao Tong University School of Medicine 20
Testing effectiveness (Phase 2)Study completedNCT00866138What this trial is testingMasitinib in Relapse or Refractory Multiple Myeloma With t(4/14) Translocation Expressing or Not FGFR3Who this might be right forMultiple Myeloma AB Science 24
Early research (Phase 1)Looking for participantsNCT06191978What this trial is testingA Phase Ia/Ib Open-label, Multiple Dose, Study to Determine the Recommended Dose, Evaluate PKs, PDs, Safety, and Activity of Venetoclax in Combination With Oral Decitabine/Cedazuridine (ASTX727) in Pediatric Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML)Who this might be right forAcute Myeloid Leukemia M.D. Anderson Cancer Center 40
Early research (Phase 1)Ended earlyNCT06163898What this trial is testingEvaluate Alnuctamab in Combination With Mezigdomide in Participants With Relapsed and/or Refractory Multiple MyelomaWho this might be right forMultiple Myeloma Celgene 4
Not applicableLooking for participantsNCT07270263What this trial is testingReduced-Dose Apixaban and Rivaroxaban Versus Low-Molecular-Weight Heparin in Patients With Hematologic MalignanciesWho this might be right forLymphomaLeukemiaMultiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma+4 more Medical University of Gdansk 100
Not applicableUnknownNCT03490084What this trial is testingImpacts on Health Outcomes and Resources Utilization of Hospital-at-home for Elderly Patients With Multiple MyelomaWho this might be right forMultiple Myeloma Assistance Publique - Hôpitaux de Paris 300
Not applicableStudy completedNCT04908852What this trial is testingFeasibility Pilot Exploring Variability in Biomarkers and PROs in AMLWho this might be right forAcute Myeloid Leukemia (AML) Dana-Farber Cancer Institute 10
Not applicableStudy completedNCT02598752What this trial is testingFeasibility and Safety of Functional Performance Testing in Patients Undergoing Hematopoietic Cell TransplantationWho this might be right forAcute Myeloid LeukemiaMyelodysplastic SyndromeHematological Malignancy+3 more Memorial Sloan Kettering Cancer Center 11
Not applicableActive Not RecruitingNCT06323447What this trial is testingPivotal Study to Validate a Novel System to Non-Invasively Detect Severe NeutropeniaWho this might be right forDiffuse Large B Cell LymphomaMultiple Myeloma Leuko Labs, Inc. 210
Testing effectiveness (Phase 2)Study completedNCT01253447What this trial is testingAKT Inhibitor MK-2206 in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaWho this might be right forAdult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)Adult Acute Monoblastic Leukemia (M5a)+12 more National Cancer Institute (NCI) 19
Testing effectiveness (Phase 2)Study completedNCT00110058What this trial is testingFludarabine and Radiation Therapy in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Chronic Phase or Accelerated Phase Chronic Myelogenous LeukemiaWho this might be right forLeukemia Fred Hutchinson Cancer Center 40
Testing effectiveness (Phase 2)UnknownNCT02047578What this trial is testingTargeted Busulfan, Fludarabine, Etoposide Conditioning Regimen for HSCT in Childhood and Adolescent ALL.Who this might be right forAcute Lymphoblastic Leukemia Seoul National University Hospital 38
Not applicableActive Not RecruitingNCT06396611What this trial is testingExercise As Intervention in Chronic Lymphocytic LeukemiaWho this might be right forChronic Lymphocytic Leukemia Universidade do Porto 11